RASHMI SALUJA

India's insurance regulator, IRDAI, has issued a show cause notice to Care Health Insurance, a subsidiary of Religare Enterprises, regarding the grant of stock options to Rashmi Saluja, who serves as the chairperson of Religare. The notice alleges t...

Rashmi Saluja and the other directors have been saying that the Burmans are not fit and proper, but they have not furnished any documentary evidence and this is made out even in the SEBI order. All these are frustrating, not just for the company, th...

Religare alleged that InGovern, founded by Shriram Subramanian, had published a defamatory report on its website without any verification and without studying information available in the public domain.

Rashmi Saluja, a doctor by training, who joined Religare as an independent director in 2018 and became its chairperson next year, said that "Anand Burman along with Arjun Lamba met me but never discussed the open offer (proposal for the financial se...

Religare Enterprises Ltd (REL) Chairperson Rashmi Saluja has denied any personal resentment towards Burmans, who are in a dispute with management over control of the financial services firm. Burmans, who own around 25% of REL through four entities, ...

IRDAI revealed that a probe into stock option allotment to Saluja is on in response to a query raised by Rahul Kanoj under the Right to Information Act (RTI) to the insurance regulator. The regulator said in its response, "The information sought is ...

This is the second time the Burman family, the largest shareholders of Religare, has accused Saluja of insider trading violations. In September, the Burmans accused Saluja of insider trading ahead of the open offer announcement.

NCLAT rejected REL's appeal regarding Burman's share acquisition. CCI ensures fair competition. Justice Khanna and Mehrotra maintained status quo. Fraud allegations, ESOP issuance, remuneration without approval are under scrutiny.

"I may have agreed that five years ago, I didn't have the experience, but after five years, three successful businesses, a company turnaround and a great team and board to support me, I will not back down," Saluja told ET in an interview. "Any alleg...

As per the disclosure on NSE on April 2, Saluja sold 6.18 lakh shares on March 26, 6.70 lakh shares on March 27, and 7.21 lakh shares on March 28. Following the transaction, Saluja’s holding in REL is reduced to 0.81% from 1.23%.

Corporate watchers said the decision by shareholders is significant given that the Burmans have announced an open offer to acquire an additional 26% of Religare's equity, a move opposed by the company's management. Currently, Religare does not have ...

In a first, the head of a prominent financial services company was offloaded from an international flight out of India for allegedly speaking rudely to the crew. The executive boarded the business class of Air India's Delhi-London flight and reporte...

The Burman family has consolidated their position in Religare Enterprises Limited (REL) by increasing their stake by around 4% through open market purchases. Their cumulative stake now stands at 25.1%. The stake hike was done at an average price bel...

Religare Enterprises has strongly responded to the Burman family's call for an investigation into the alleged allotment of an 8% share of Religare Finvest to REL Chairman Rashmi Saluja. Denying the claims, Religare Enterprises stated that the inform...

Religare Enterprises has clarified that it has not violated rules on issuance of securities to key managerial personnel, as its non-bank lending arm, Religare Finvest, did not issue any shares to its chairperson, Rashmi Saluja. The company stated th...

The Burman family has accused Rashmi Saluja of acquiring a significant amount of remuneration through Employee Stock Ownership Plans (ESOPs) at Religare Enterprises Limited (REL), Care Health Insurance Limited, and RFL without approval and disclosur...

"Subsequent to the passing of enabling special resolution by the shareholders of RFL with respect to 'Item No 5', RFL has not placed any proposal with NRC till date for grant of above mentioned ESOPs to CMD. Since no new shares were issued/allotted ...

The award in the unlisted subsidiary ascribed its value in a band of Rs150-260 crore. Previously, proxy advisory firm InGovern had estimated the Esops awarded to Saluja in Religare Enterprises as well as its health insurance subsidiary Care Health I...

The board has no shareholder representation. It has six members including Chairperson Rashmi Saluja who has an executive role. All the other members are retired civil servants except Hamid Ahmed, who is the CEO of Hamdard Laboratories and chancellor...